{
    "info": {
        "nct_id": "NCT05721222",
        "official_title": "Phase 1/2 Study of PRO1160 in Patients With Renal Cell Carcinoma (RCC), Nasopharyngeal Carcinoma (NPC), or Non-Hodgkin Lymphoma (NHL)",
        "inclusion_criteria": "* Pathologically confirmed metastatic or unresectable solid malignancy including Renal Cell carcinoma, Nasopharyngeal carcinoma or Stage III or IV Non Hodgkin Lymphoma\n* Relapsed or refractory disease following prior systemic therapies known to confer medical benefit\n* Willing to provide a tumor sample (archive tissue or fresh biopsy)\n* ECOG performance status 0 or 1\n* Measurable disease per RECIST v1.1 for RCC and NPC and per Lugano for NHL\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Prior treatment with anti-CD70 directed therapy\n* Other malignancy within 3 years\n* Active CNS metastases (treated, stable CNS metastases are allowed)\n* Uncontrolled Grade 3 or greater infection within 2 weeks\n* Positive for HBV, HCV or HIV\n* Use of a strong P450 CYP3A inhibitor within 14 days (dose escalation only)\n* Additional protocol defined inclusion/exclusion criteria may apply",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ECOG performance status 0 or 1",
            "criterions": [
                {
                    "exact_snippets": "ECOG performance status 0 or 1",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Relapsed or refractory disease following prior systemic therapies known to confer medical benefit",
            "criterions": [
                {
                    "exact_snippets": "Relapsed or refractory disease",
                    "criterion": "disease status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": [
                                "relapsed",
                                "refractory"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "following prior systemic therapies known to confer medical benefit",
                    "criterion": "prior systemic therapies",
                    "requirements": [
                        {
                            "requirement_type": "history of prior therapy",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "type of therapy",
                            "expected_value": "systemic therapies known to confer medical benefit"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Willing to provide a tumor sample (archive tissue or fresh biopsy)",
            "criterions": [
                {
                    "exact_snippets": "Willing to provide a tumor sample (archive tissue or fresh biopsy)",
                    "criterion": "tumor sample",
                    "requirements": [
                        {
                            "requirement_type": "willingness to provide",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "sample type",
                            "expected_value": [
                                "archive tissue",
                                "fresh biopsy"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Pathologically confirmed metastatic or unresectable solid malignancy including Renal Cell carcinoma, Nasopharyngeal carcinoma or Stage III or IV Non Hodgkin Lymphoma",
            "criterions": [
                {
                    "exact_snippets": "Pathologically confirmed metastatic or unresectable solid malignancy",
                    "criterion": "solid malignancy",
                    "requirements": [
                        {
                            "requirement_type": "confirmation method",
                            "expected_value": "pathologically confirmed"
                        },
                        {
                            "requirement_type": "metastatic status",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "resectability",
                            "expected_value": "unresectable"
                        }
                    ]
                },
                {
                    "exact_snippets": "including Renal Cell carcinoma",
                    "criterion": "Renal Cell carcinoma",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "including ... Nasopharyngeal carcinoma",
                    "criterion": "Nasopharyngeal carcinoma",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "including ... Stage III or IV Non Hodgkin Lymphoma",
                    "criterion": "Non Hodgkin Lymphoma",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "Stage III",
                                "Stage IV"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Measurable disease per RECIST v1.1 for RCC and NPC and per Lugano for NHL",
            "criterions": [
                {
                    "exact_snippets": "Measurable disease per RECIST v1.1 for RCC and NPC",
                    "criterion": "measurable disease (RCC and NPC)",
                    "requirements": [
                        {
                            "requirement_type": "assessment method",
                            "expected_value": "RECIST v1.1"
                        }
                    ]
                },
                {
                    "exact_snippets": "Measurable disease ... per Lugano for NHL",
                    "criterion": "measurable disease (NHL)",
                    "requirements": [
                        {
                            "requirement_type": "assessment method",
                            "expected_value": "Lugano"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Prior treatment with anti-CD70 directed therapy",
            "criterions": [
                {
                    "exact_snippets": "Prior treatment with anti-CD70 directed therapy",
                    "criterion": "prior treatment with anti-CD70 directed therapy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Positive for HBV, HCV or HIV",
            "criterions": [
                {
                    "exact_snippets": "Positive for HBV",
                    "criterion": "HBV infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Positive for ... HCV",
                    "criterion": "HCV infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Positive for ... HIV",
                    "criterion": "HIV infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Uncontrolled Grade 3 or greater infection within 2 weeks",
            "criterions": [
                {
                    "exact_snippets": "Uncontrolled Grade 3 or greater infection within 2 weeks",
                    "criterion": "infection",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        },
                        {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "grade"
                            }
                        },
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Additional protocol defined inclusion/exclusion criteria may apply",
            "criterions": [
                {
                    "exact_snippets": "Additional protocol defined inclusion/exclusion criteria may apply",
                    "criterion": "protocol defined inclusion/exclusion criteria",
                    "requirements": [
                        {
                            "requirement_type": "applicability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Use of a strong P450 CYP3A inhibitor within 14 days (dose escalation only)",
            "criterions": [
                {
                    "exact_snippets": "Use of a strong P450 CYP3A inhibitor within 14 days (dose escalation only)",
                    "criterion": "use of strong P450 CYP3A inhibitor",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 14,
                                "unit": "days"
                            }
                        },
                        {
                            "requirement_type": "context",
                            "expected_value": "dose escalation only"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Other malignancy within 3 years",
            "criterions": [
                {
                    "exact_snippets": "Other malignancy within 3 years",
                    "criterion": "other malignancy",
                    "requirements": [
                        {
                            "requirement_type": "time since diagnosis or treatment",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active CNS metastases (treated, stable CNS metastases are allowed)",
            "criterions": [
                {
                    "exact_snippets": "Active CNS metastases (treated, stable CNS metastases are allowed)",
                    "criterion": "CNS metastases",
                    "requirements": [
                        {
                            "requirement_type": "activity status",
                            "expected_value": "not active"
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}